Ashley-Marie Y. Green-Lott MD, Ananta Wadhwa BS, Anissa V. Bailey MPH, Lorna Kwan MPH, Candace L. Haroldsen MSPH, Jeremy B. Shelton MD, MSHS, Michael S. Lewis MD, David O. Beenhouwer MD, Karim Chamie MD, Brent S. Rose MD, Kara N. Maxwell MD, PhD, Nicholas G. Nickols MD, PhD, Kosj Yamoah MD, PhD, Michael J. Kelley MD, Timothy R. Rebbeck PhD, Martin Schoen MD, MPH, Matthew B. Rettig MD, Hari S. Iyer ScD, Isla P. Garraway MD, PhD
{"title":"在退伍军人健康管理局接受治疗的越战退伍军人中前列腺癌的发病率和结果","authors":"Ashley-Marie Y. Green-Lott MD, Ananta Wadhwa BS, Anissa V. Bailey MPH, Lorna Kwan MPH, Candace L. Haroldsen MSPH, Jeremy B. Shelton MD, MSHS, Michael S. Lewis MD, David O. Beenhouwer MD, Karim Chamie MD, Brent S. Rose MD, Kara N. Maxwell MD, PhD, Nicholas G. Nickols MD, PhD, Kosj Yamoah MD, PhD, Michael J. Kelley MD, Timothy R. Rebbeck PhD, Martin Schoen MD, MPH, Matthew B. Rettig MD, Hari S. Iyer ScD, Isla P. Garraway MD, PhD","doi":"10.1002/cncr.70007","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies reported inconsistent associations of AOE and PCa incidence and outcomes. In this nationwide cohort study, Vietnam veterans who received VA care were evaluated for associations of AOE and PCa incidence and adverse outcomes.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Vietnam veterans 17–25 years old during military service (1962–1971) who received VA health care between 2005 and 2020 were stratified by presumptive AOE assigned by the VA and followed until death from any cause or censoring on September 31, 2023. Multivariable Cox models permitted estimation of adjusted hazard ratios (aHRs) of AOE with PCa incidence, de novo metastasis (DNM), any metastasis, metastatic castration-resistant PCa (mCRPC), all-cause mortality (ACM), or PCa-specific mortality (PCSM).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 2.6 million Vietnam veterans at risk for PCa, 779,472 (30%) had AOE. Compared to unexposed veterans, AOE veterans had higher PCa risk (aHR, 1.15; 95% confidence interval [CI], 1.15–1.16), higher DNM (aHR, 1.17; 95% CI, 1.16–1.17), any metastasis (aHR, 1.17; 95% CI, 1.16–1.17), mCRPC (aHR, 1.17; 95% CI, 1.16–1.17), ACM (aHR, 1.41; 95% CI, 1.41–1.42), and PCSM (aHR, 1.17; 95% CI, 1.16–1.17) in adjusted models. Sensitivity analyses suggested robustness of association between AOE and all-cause mortality, but selection bias could explain associations with PCa outcomes.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Presumptive AOE was associated with higher PCa incidence, mortality, and adverse outcomes. Although associations may not be causal, AOE may predict worse PCa outcomes in the Veterans Affairs.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 15","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.70007","citationCount":"0","resultStr":"{\"title\":\"Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration\",\"authors\":\"Ashley-Marie Y. Green-Lott MD, Ananta Wadhwa BS, Anissa V. Bailey MPH, Lorna Kwan MPH, Candace L. Haroldsen MSPH, Jeremy B. Shelton MD, MSHS, Michael S. Lewis MD, David O. Beenhouwer MD, Karim Chamie MD, Brent S. Rose MD, Kara N. Maxwell MD, PhD, Nicholas G. Nickols MD, PhD, Kosj Yamoah MD, PhD, Michael J. Kelley MD, Timothy R. Rebbeck PhD, Martin Schoen MD, MPH, Matthew B. Rettig MD, Hari S. Iyer ScD, Isla P. Garraway MD, PhD\",\"doi\":\"10.1002/cncr.70007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies reported inconsistent associations of AOE and PCa incidence and outcomes. In this nationwide cohort study, Vietnam veterans who received VA care were evaluated for associations of AOE and PCa incidence and adverse outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Vietnam veterans 17–25 years old during military service (1962–1971) who received VA health care between 2005 and 2020 were stratified by presumptive AOE assigned by the VA and followed until death from any cause or censoring on September 31, 2023. Multivariable Cox models permitted estimation of adjusted hazard ratios (aHRs) of AOE with PCa incidence, de novo metastasis (DNM), any metastasis, metastatic castration-resistant PCa (mCRPC), all-cause mortality (ACM), or PCa-specific mortality (PCSM).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Among 2.6 million Vietnam veterans at risk for PCa, 779,472 (30%) had AOE. Compared to unexposed veterans, AOE veterans had higher PCa risk (aHR, 1.15; 95% confidence interval [CI], 1.15–1.16), higher DNM (aHR, 1.17; 95% CI, 1.16–1.17), any metastasis (aHR, 1.17; 95% CI, 1.16–1.17), mCRPC (aHR, 1.17; 95% CI, 1.16–1.17), ACM (aHR, 1.41; 95% CI, 1.41–1.42), and PCSM (aHR, 1.17; 95% CI, 1.16–1.17) in adjusted models. Sensitivity analyses suggested robustness of association between AOE and all-cause mortality, but selection bias could explain associations with PCa outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Presumptive AOE was associated with higher PCa incidence, mortality, and adverse outcomes. Although associations may not be causal, AOE may predict worse PCa outcomes in the Veterans Affairs.</p>\\n </section>\\n </div>\",\"PeriodicalId\":138,\"journal\":{\"name\":\"Cancer\",\"volume\":\"131 15\",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.70007\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cncr.70007\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.70007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration
Background
Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies reported inconsistent associations of AOE and PCa incidence and outcomes. In this nationwide cohort study, Vietnam veterans who received VA care were evaluated for associations of AOE and PCa incidence and adverse outcomes.
Methods
Vietnam veterans 17–25 years old during military service (1962–1971) who received VA health care between 2005 and 2020 were stratified by presumptive AOE assigned by the VA and followed until death from any cause or censoring on September 31, 2023. Multivariable Cox models permitted estimation of adjusted hazard ratios (aHRs) of AOE with PCa incidence, de novo metastasis (DNM), any metastasis, metastatic castration-resistant PCa (mCRPC), all-cause mortality (ACM), or PCa-specific mortality (PCSM).
Results
Among 2.6 million Vietnam veterans at risk for PCa, 779,472 (30%) had AOE. Compared to unexposed veterans, AOE veterans had higher PCa risk (aHR, 1.15; 95% confidence interval [CI], 1.15–1.16), higher DNM (aHR, 1.17; 95% CI, 1.16–1.17), any metastasis (aHR, 1.17; 95% CI, 1.16–1.17), mCRPC (aHR, 1.17; 95% CI, 1.16–1.17), ACM (aHR, 1.41; 95% CI, 1.41–1.42), and PCSM (aHR, 1.17; 95% CI, 1.16–1.17) in adjusted models. Sensitivity analyses suggested robustness of association between AOE and all-cause mortality, but selection bias could explain associations with PCa outcomes.
Conclusions
Presumptive AOE was associated with higher PCa incidence, mortality, and adverse outcomes. Although associations may not be causal, AOE may predict worse PCa outcomes in the Veterans Affairs.
期刊介绍:
The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society.
CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research